Plant Comparison
Midland Hawthorn vs Wild Yam
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Midland Hawthorn and Wild Yam: they share 5 indicated uses (arthritis / joint pain, inflammation (general), menstrual cramps, …); 2 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Midland Hawthorn | Wild Yam | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 1/10 | 2/10 | Comparable evidence |
| Inflammation (general) | 1/10 | 2/10 | Comparable evidence |
| Menstrual cramps | 1/10 | 2/10 | Comparable evidence |
| Muscle spasm | 1/10 | 2/10 | Comparable evidence |
| Skin irritation | 1/10 | 2/10 | Comparable evidence |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
The principal cardioactive and antioxidant constituents, the basis for extract standardisation.
Additional antioxidant constituents of the flower, leaf and fruit.
Diosgenin is an industrial precursor for making steroid hormones in the laboratory, but it is NOT converted into hormones in the human body. Oral bioavailability of diosgenin is low; in animal studies orally administered diosgenin restored skin thickness in ovariectomised mice and lowered blood lipids.
Pharmacological Actions
Antispasmodic / analgesic for menstrual cramps and muscle spasm (antinociceptive in animal models)
Anti-inflammatory for joint and inflammatory pain
Antispasmodic / analgesic for menstrual cramps and muscle spasm (antinociceptive in animal models)
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from sedative action
inferred from antispasmodic action
inferred from antispasmodic action
inferred from anti-inflammatory action
inferred from anticancer action
inferred from anti-inflammatory action
Traditional support for menopausal symptoms (see safety note - it does NOT act as a natural progesterone) - a placebo-controlled crossover RCT of topical wild yam cream found little effect on menopausal symptoms, lipids or hormones
Antispasmodic / analgesic for menstrual cramps and muscle spasm (antinociceptive in animal models)
Antispasmodic / analgesic for menstrual cramps and muscle spasm (antinociceptive in animal models)
Anti-inflammatory for joint and inflammatory pain
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Generally safe and well tolerated. High doses may cause low blood pressure and sedation. May interact with cardiac glycosides (digoxin) and antihypertensive drugs. Consult a physician before using with existing heart medications.
Duke (2002) rates hawthorn (Crataegus spp., including C. laevigata) as a triple-plus herb (+++) with Commission E approval (score 2-3) for decreasing cardiac output in functional Stage II heart insufficiency (NYHA). Clinical evidence supports hawthorn standardized extracts (80-500 mg, standardized to flavonoids or procyanidins) for angina, arrhythmia, atherosclerosis, and hypertension. Hawthorn may potentiate digitalis and other cardiac medications and is not considered suitable for self-medication without professional guidance (Duke, 2002).
IMPORTANT myth-bust: wild yam / diosgenin is NOT converted into progesterone or DHEA in the body, so it does not work as a 'natural progesterone' - claims to that effect are incorrect. Consistent with this, a randomized placebo-controlled crossover trial of topical wild yam cream found no significant change in symptoms, serum/salivary progesterone, oestradiol, FSH or lipids.
Generally well tolerated orally (no acute or subchronic toxicity in animal studies); large doses may cause nausea or vomiting. Avoid medicinal doses in pregnancy and breastfeeding and in hormone-sensitive conditions as a precaution.
External Ids
Botanical Description
Small deciduous tree or large shrub with thorny branches and glossy, shallowly lobed leaves (less deeply cut than common hawthorn). Clusters of small, five-petalled white (occasionally pink) flowers with a strong scent appear in spring, followed by small red berries (haws), each usually containing two seeds (nutlets).[1]
Twining, herbaceous perennial vine with heart-shaped leaves arising from a knotty, woody, cinnamon-brown rhizome ('root'). Small, inconspicuous greenish-yellow flowers are borne on separate male and female plants, followed on female plants by small three-winged seed capsules.[10]
Habitat
Harvesting
Flowers are picked as they open in spring, leaves are picked with the young flowering shoots, and the ripe red berries (haws) are gathered in autumn; all three parts are used, often combined, in hawthorn preparations.[1]
The knotty rhizome is dug in autumn once the aerial vine has died back, then cleaned and dried.
Traditional Uses
Hawthorn flower, leaf and berry have a long European tradition, and substantial modern clinical study, as a cardiovascular tonic - supporting heart function, mild circulatory complaints and calming nervous tension - reflected in its traditional use for 'heart strengthening' and its modern standing as a well-studied botanical for mild heart failure symptoms.[1]
Wild yam root has a Native American and Eclectic-medicine history as an antispasmodic remedy for colic, menstrual cramps and rheumatic joint pain (reflected in the old names 'colic root' and 'rheumatism root'); despite a persistent modern myth, its diosgenin content is not converted into progesterone or other hormones in the human body.[10]
Preparations
Leaf-and-flower extract standardised to flavonoid or oligomeric proanthocyanidin content, taken as tablets or capsules; the best-studied clinical form.
Dosage
The EU herbal monograph on Crataegus spp., folium cum flore gives dry extracts in divided daily doses of 240-900 mg (single dose 80-450 mg) or, for one quantified extract, 570-1750 mg daily (single dose 190-350 mg), in adults and elderly. If symptoms persist longer than 2 weeks a doctor should be consulted, and hawthorn is never used as a substitute for prescribed heart medication without medical supervision. Educational reference only, not a prescription.
The EU herbal monograph gives 1-2 g of the comminuted leaf and flower in 150 mL of boiling water as an infusion, up to 4 times daily (maximum 6 g daily), in adults and elderly. Educational reference only, not a prescription.
Not documented
References
Drug Class Interactions
Not documented
Lookalikes Review
References & Sources
- Fong, H.H.S. and Bauman, J.L (2002) 'Hawthorn', Journal of Cardiovascular Nursing, 16(4), pp. 1-8. doi:10.1097/00005082-200207000-00002 Traditional / reference
https://doi.org/10.1097/00005082-200207000-00002 - Orhan, I.E (2018) 'Phytochemical and Pharmacological Activity Profile of Crataegus oxyacantha L. (Hawthorn) - A Cardiotonic Herb', Current Medicinal Chemistry, 25(37), pp. 4854-4865. doi:10.2174/0929867323666160919095519 Traditional / reference
https://doi.org/10.2174/0929867323666160919095519 - Ahmadipour, B., Kalantar, M., Abaszadeh, S. and Hassanpour, H (2024) 'Antioxidant and antihyperlipidemic effects of hawthorn extract (Crataegus oxyacantha) in broiler chickens', Veterinary Medicine and Science, 10(3), pp. e1414. doi:10.1002/vms3.1414 Preclinical
https://doi.org/10.1002/vms3.1414 - Rigelsky, J.M. and Sweet, B.V (2002) 'Hawthorn: pharmacology and therapeutic uses', American Journal of Health-System Pharmacy, 59(5), pp. 417-422. doi:10.1093/ajhp/59.5.417 Meta-analysis / review
https://doi.org/10.1093/ajhp/59.5.417 - Saeedi, G., Jeivad, F., Goharbari, M., Gheshlaghi, G.H. and Sabzevari, O (2018) 'Ethanol Extract of Crataegus Oxyacantha L. Ameliorate Dietary Non-Alcoholic Fatty Liver Disease in Rat', Drug Research, 68(10), pp. 553-559. doi:10.1055/a-0579-7532 Preclinical
https://doi.org/10.1055/a-0579-7532 - Mecheri, A., Benabderrahmane, W., Amrani, A., Boubekri, N., Benayache, F., Benayache, S. and Zama, D (2019) 'Hepatoprotective Effects of Algerian Crataegus oxyacantha Leaves', Recent Patents on Food, Nutrition & Agriculture, 10(1), pp. 70-75. doi:10.2174/2212798410666180730095456 Preclinical
https://doi.org/10.2174/2212798410666180730095456 - Benabderrahmane, W., Lores, M., Benaissa, O., Lamas, J.P., de Miguel, T., Amrani, A., Benayache, F. and Benayache, S (2019) 'Polyphenolic content and bioactivities of Crataegus oxyacantha L. (Rosaceae)', Natural Product Research, 35(4), pp. 627-632. doi:10.1080/14786419.2019.1582044 Preclinical
https://doi.org/10.1080/14786419.2019.1582044 - Ali, M., Muhammad, S., Shah, M.R., Khan, A., Rashid, U., Farooq, U., Ullah, F., Sadiq, A., Ayaz, M., Ali, M., Ahmad, M. and Latif, A (2017) 'Neurologically Potent Molecules from Crataegus oxyacantha; Isolation, Anticholinesterase Inhibition, and Molecular Docking', Frontiers in Pharmacology, 8, pp. 327. doi:10.3389/fphar.2017.00327 Preclinical
https://doi.org/10.3389/fphar.2017.00327 - Cuevas-Duran, R.E., Medrano-Rodriguez, J.C., Sanchez-Aguilar, M., Soria-Castro, E., Rubio-Ruiz, M.E., Del Valle-Mondragon, L., Sanchez-Mendoza, A., Torres-Narvaez, J.C., Pastelin-Hernandez, G. and Ibarra-Lara, L (2017) 'Extracts of Crataegus oxyacantha and Rosmarinus officinalis Attenuate Ischemic Myocardial Damage by Decreasing Oxidative Stress and Regulating the Production of Cardiac Vasoactive Agents', International Journal of Molecular Sciences, 18(11), pp. 2412. doi:10.3390/ijms18112412 Preclinical
https://doi.org/10.3390/ijms18112412 - Alp, H., Soner, B.C., Baysal, T. and Sahin, A.S (2014) 'Protective effects of Hawthorn (Crataegus oxyacantha) extract against digoxin-induced arrhythmias in rats', Anatolian Journal of Cardiology, 15(12), pp. 970-975. doi:10.5152/akd.2014.5869 Preclinical
https://doi.org/10.5152/akd.2014.5869 - Rothfuss, M.A., Pascht, U. and Kissling, G (2001) 'Effect of long-term application of Crataegus oxyacantha on ischemia and reperfusion induced arrhythmias in rats', Arzneimittel-Forschung, 51(1), pp. 24-28. doi:10.1055/s-0031-1299998 Preclinical
https://doi.org/10.1055/s-0031-1299998 - Khan, A., Akram, M., Thiruvengadam, M., Daniyal, M., Zakki, S.A., Munir, N., Zainab, R., Heydari, M., Mosavat, S.H., Rebezov, M. and Shariati, M.A (2022) 'Anti-anxiety Properties of Selected Medicinal Plants', Current Pharmaceutical Biotechnology, 23(8), pp. 1041-1060. doi:10.2174/1389201022666210122125131 Meta-analysis / review
https://doi.org/10.2174/1389201022666210122125131 - Rastogi, S., Pandey, M.M. and Rawat, A.K.S (2015) 'Traditional herbs: a remedy for cardiovascular disorders', Phytomedicine, 23(11), pp. 1082-1089. doi:10.1016/j.phymed.2015.10.012 Meta-analysis / review
https://doi.org/10.1016/j.phymed.2015.10.012 - European Medicines Agency (2016) 'European Union herbal monograph on Crataegus spp., folium cum flore'. Traditional / reference
https://scholar.google.com/scholar?q=European%20Union%20herbal%20monograph%20on%20Crataegus%20spp.%2C%20folium%20cum%20flore - Hendel, N. and Hendel, M (2014) 'Hedgerow Medicine'. Traditional / reference
https://scholar.google.com/scholar?q=Hedgerow%20Medicine - Pittler, M.H., Guo, R. and Ernst, E (2008) 'Hawthorn extract for treating chronic heart failure'. Traditional / reference
https://scholar.google.com/scholar?q=Hawthorn%20extract%20for%20treating%20chronic%20heart%20failure - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Tankanow, R., Tamer, H.R., Streetman, D.S., Smith, S.G., Welton, J.L., Annesley, T., Aaronson, K.D. and Bleske, B.E (2003) 'Interaction study between digoxin and a preparation of hawthorn (Crataegus oxyacantha)', Journal of Clinical Pharmacology, 43(6), pp. 637-642. doi:10.1177/0091270003253417 Randomized trial
https://doi.org/10.1177/0091270003253417 - Pittler, M.H., Guo, R. and Ernst, E (2008) 'Hawthorn extract for treating chronic heart failure', Cochrane Database of Systematic Reviews, 2008(1), pp. CD005312. doi:10.1002/14651858.CD005312.pub2 Meta-analysis / review
https://doi.org/10.1002/14651858.CD005312.pub2 - Pittler, M.H., Guo, R. and Ernst, E (2008) 'Hawthorn extract for treating chronic heart failure', Cochrane Database of Systematic Reviews, 2008(1), pp. CD005312. doi:10.1002/14651858.CD005312.pub2 Meta-analysis / review
https://doi.org/10.1002/14651858.CD005312.pub2 - Ghasemzadeh Rahbardar, M. and Hosseinzadeh, H (2024) 'Therapeutic potential of hypnotic herbal medicines: A comprehensive review', Phytotherapy Research, 38(6), pp. 3037-3059. doi:10.1002/ptr.8201 Meta-analysis / review
https://doi.org/10.1002/ptr.8201 - Block, K.I., Gyllenhaal, C. and Mead, M.N (2004) 'Safety and efficacy of herbal sedatives in cancer care', Integrative Cancer Therapies, 3(2), pp. 128-148. doi:10.1177/1534735404265003 Meta-analysis / review
https://doi.org/10.1177/1534735404265003
- Depypere, H.T. and Comhaire, F.H (2013) 'Herbal preparations for the menopause: beyond isoflavones and black cohosh', Maturitas, 77(2), pp. 191-194. doi:10.1016/j.maturitas.2013.11.001 Traditional / reference
https://doi.org/10.1016/j.maturitas.2013.11.001 - Cai, B., Zhang, Y., Wang, Z., Xu, D. et al (2020) 'Therapeutic Potential of Diosgenin and Its Major Derivatives against Neurological Diseases: Recent Advances', Oxidative Medicine and Cellular Longevity, 2020, pp. 3153082. doi:10.1155/2020/3153082 Traditional / reference
https://doi.org/10.1155/2020/3153082 - Raj, P.S., Bergfeld, W.F., Belsito, D.V., Cohen, D.E. et al (2023) 'Safety Assessment of Dioscorea Villosa (Wild Yam) Root Extract as Used in Cosmetics', International Journal of Toxicology, 42(3_suppl), pp. 29S-31S. doi:10.1177/10915818231204230 Traditional / reference
https://doi.org/10.1177/10915818231204230 - Dong, S., Nikolic, D., Simmler, C., Qiu, F., van Breemen, R.B., Soejarto, D.D., Pauli, G.F. and Chen, S (2012) 'Diarylheptanoids from Dioscorea villosa (wild yam)', Journal of Natural Products, 75(12), pp. 2168-2177. doi:10.1021/np300603z Preclinical
https://doi.org/10.1021/np300603z - Dong, S., Cai, G., Napolitano, J.G., Nikolic, D., Lankin, D.C., McAlpine, J.B., van Breemen, R.B., Soejarto, D.D., Pauli, G.F. and Chen, S (2013) 'Lipidated steroid saponins from Dioscorea villosa (wild yam)', Fitoterapia, 91, pp. 113-124. doi:10.1016/j.fitote.2013.07.018 Preclinical
https://doi.org/10.1016/j.fitote.2013.07.018 - Wojcikowski, K., Wohlmuth, H., Johnson, D.W. and Gobe, G (2008) 'Dioscorea villosa (wild yam) induces chronic kidney injury via pro-fibrotic pathways', Food and Chemical Toxicology, 46(9), pp. 3122-3131. doi:10.1016/j.fct.2008.06.090 Preclinical
https://doi.org/10.1016/j.fct.2008.06.090 - Mazzio, E., Almalki, A., Darling-Reed, S.F. and Soliman, K.F.A (2021) 'Effects of wild yam root (Dioscorea villosa) extract on the gene expression profile of triple-negative breast cancer cells', Cancer Genomics & Proteomics, 18(6), pp. 735-755. doi:10.21873/cgp.20294 Preclinical
https://doi.org/10.21873/cgp.20294 - Ali, Z., Smillie, T.J. and Khan, I.A (2013) 'Cholestane steroid glycosides from the rhizomes of Dioscorea villosa (wild yam)', Carbohydrate Research, 370, pp. 86-91. doi:10.1016/j.carres.2012.12.022 Preclinical
https://doi.org/10.1016/j.carres.2012.12.022 - Manda, V.K., Avula, B., Ali, Z., Wong, Y., Smillie, T.J., Khan, I.A. and Khan, S.I (2013) 'Characterization of in vitro ADME properties of diosgenin and dioscin from Dioscorea villosa', Planta Medica, 79(15), pp. 1421-1428. doi:10.1055/s-0033-1350699 Preclinical
https://doi.org/10.1055/s-0033-1350699 - Lima, C.M., Lima, A.K., Melo, M.G.D., Serafini, M.R., Oliveira, D.L., de Almeida, E.B., Barreto, R.S.S., Nogueira, P.C., Moraes, V.R.S., Oliveira, E.R.A., de Albuquerque, R.L.C., Quintans-Junior, L.J. and Araujo, A.A.S (2013) 'Bioassay-guided evaluation of Dioscorea villosa - an acute and subchronic toxicity, antinociceptive and anti-inflammatory approach', BMC Complementary and Alternative Medicine. doi:10.1186/1472-6882-13-195 Preclinical
https://doi.org/10.1186/1472-6882-13-195 - Avula, B., Wang, Y., Wang, M., Ali, Z., Smillie, T.J., Zweigenbaum, J. and Khan, I.A (2014) 'Characterization of steroidal saponins from Dioscorea villosa and D. cayenensis using ultrahigh performance liquid chromatography/electrospray ionization quadrupole time-of-flight mass spectrometry', Planta Medica, 80(4), pp. 321-329. doi:10.1055/s-0033-1360330 Preclinical
https://doi.org/10.1055/s-0033-1360330 - Siddiqui, M.A., Ali, Z., Chittiboyina, A.G. and Khan, I.A (2018) 'Hepatoprotective effect of steroidal glycosides from Dioscorea villosa on hydrogen peroxide-induced hepatotoxicity in HepG2 cells', Frontiers in Pharmacology, 9, pp. 797. doi:10.3389/fphar.2018.00797 Preclinical
https://doi.org/10.3389/fphar.2018.00797 - Hayes, P.Y., Lambert, L.K., Lehmann, R., Penman, K., Kitching, W. and De Voss, J.J (2007) 'Complete 1H and 13C assignments of the four major saponins from Dioscorea villosa (wild yam)', Magnetic Resonance in Chemistry, 45(11), pp. 1001-1005. doi:10.1002/mrc.2071 Preclinical
https://doi.org/10.1002/mrc.2071 - Okawara, M. and Tokudome, Y. and Todo, H. and Sugibayashi, K. and Hashimoto, F (2013) 'Enhancement of diosgenin distribution in the skin by cyclodextrin complexation following oral administration', Biological & Pharmaceutical Bulletin, 36(1), pp. 36--40. doi:10.1248/bpb.b12-00467 Preclinical
https://doi.org/10.1248/bpb.b12-00467 - Komesaroff, P.A., Black, C.V., Cable, V. and Sudhir, K (2001) 'Effects of wild yam extract on menopausal symptoms, lipids and sex hormones in healthy menopausal women', Climacteric, 4(2), pp. 144--150. doi:10.1080/cmt.4.2.144.150 Randomized trial
https://doi.org/10.1080/cmt.4.2.144.150
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.